Company intelligence / Profile preview

Kehui Zhiyao

Shenzhen, Guangdong, China

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Kehui Zhiyao is a biotechnology company focused on the integration of artificial intelligence and traditional drug discovery to develop innovative small molecule therapeutics. Headquartered in Shenzhen with R&D centers in Beijing and Boston, the company leverages its proprietary AI platform to target challenging biological pathways in oncology and immunology. The leadership team, led by Dr. Zhenping Zhu, brings extensive experience from global pharmaceutical companies to advance a pipeline of high-potential candidates. Kehui Zhiyao's approach combines computational efficiency with rigorous experimental validation to address significant unmet medical needs.

Therapeutic areas: ImmunologyOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Kehui Zhiyao.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kehui Zhiyao.

Explore the full profile